Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascaline Boudou-Rouquette

Showing results (41-50 of 122) with videos related to

Pageof 13
Sort By:
Lung Cancer (Amsterdam, Netherlands)|February 28, 2012
Pemetrexed, oxaliplatin and bevacizumab as first-line treatment in patients with stage IV non-small cell lung cancerOlivier Mir, Pascaline Boudou-Rouquette, Julie Giroux, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 27, 2015
Effect of glucuronidation on transport and tissue accumulation of tyrosine kinase inhibitors: consequences for the clinical management of sorafenib and regorafenibCamille Tlemsani, Olivier Huillard, Jennifer Arrondeau, et al.
Cancer Chemotherapy and Pharmacology|September 16, 2020
Nivolumab increases pulmonary artery pressure in patients treated for non-small cell lung cancerLudovic Fournel, Pascaline Boudou-Rouquette, Mathilde Prieto, et al.
Journal of Geriatric Oncology|August 26, 2019
Potential drug-drug interactions and risk of unplanned hospitalization in older patients with cancer: A survey of the prospective ELCAPA (ELderly CAncer PAtients) cohortGuillaume Beinse, Delphine Reitter, Lauriane Segaux, et al.
Expert Opinion on Drug Safety|April 4, 2014
Drug safety evaluation of sorafenib for treatment of solid tumors: consequences for the risk assessment and management of cancer patientsOlivier Huillard, Emilie Boissier, Benoit Blanchet, et al.
The American Journal of the Medical Sciences|July 26, 2018
BRCA2 Loss-of-Function and High Sensitivity to Cisplatin-Based Chemotherapy in a Patient With a Pleomorphic Soft Tissue Sarcoma: Effect of Genomic MedicineCamille Tlemsani, Eric Pasmant, Pascaline Boudou-Rouquette, et al.
International Journal of Cancer|November 19, 2025
Fertility preservation in women with sarcoma: A real-world experienceGuillaume Beinse, Pascaline Boudou-Rouquette, Sixtine de Percin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 14, 2025
Factors associated with medication adherence trajectory among patients treated with oral anticancer drugs: a multicentre cohort studyGermain Perrin, Audrey Thomas-Schoemann, François Goldwasser, et al.
Expert Opinion on Investigational Drugs|January 21, 2015
Investigational therapies up to Phase II which target PDGF receptors: potential anti-cancer therapeuticsJennifer Arrondeau, Olivier Huillard, Camille Tlemsani, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 30, 2024
Pulmonary metastasectomy for sarcoma: Insights from a referral-center cohortThomas Charrier, Edouard-Frédéric Robin, Vincent De Pauw, et al.
Pageof 13

Showing results (41-50 of 122) with videos related to

Sort By:
Pageof 13
Lung Cancer (Amsterdam, Netherlands)|February 28, 2012
Pemetrexed, oxaliplatin and bevacizumab as first-line treatment in patients with stage IV non-small cell lung cancerOlivier Mir, Pascaline Boudou-Rouquette, Julie Giroux, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 27, 2015
Effect of glucuronidation on transport and tissue accumulation of tyrosine kinase inhibitors: consequences for the clinical management of sorafenib and regorafenibCamille Tlemsani, Olivier Huillard, Jennifer Arrondeau, et al.
Cancer Chemotherapy and Pharmacology|September 16, 2020
Nivolumab increases pulmonary artery pressure in patients treated for non-small cell lung cancerLudovic Fournel, Pascaline Boudou-Rouquette, Mathilde Prieto, et al.
Journal of Geriatric Oncology|August 26, 2019
Potential drug-drug interactions and risk of unplanned hospitalization in older patients with cancer: A survey of the prospective ELCAPA (ELderly CAncer PAtients) cohortGuillaume Beinse, Delphine Reitter, Lauriane Segaux, et al.
Expert Opinion on Drug Safety|April 4, 2014
Drug safety evaluation of sorafenib for treatment of solid tumors: consequences for the risk assessment and management of cancer patientsOlivier Huillard, Emilie Boissier, Benoit Blanchet, et al.
The American Journal of the Medical Sciences|July 26, 2018
BRCA2 Loss-of-Function and High Sensitivity to Cisplatin-Based Chemotherapy in a Patient With a Pleomorphic Soft Tissue Sarcoma: Effect of Genomic MedicineCamille Tlemsani, Eric Pasmant, Pascaline Boudou-Rouquette, et al.
International Journal of Cancer|November 19, 2025
Fertility preservation in women with sarcoma: A real-world experienceGuillaume Beinse, Pascaline Boudou-Rouquette, Sixtine de Percin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 14, 2025
Factors associated with medication adherence trajectory among patients treated with oral anticancer drugs: a multicentre cohort studyGermain Perrin, Audrey Thomas-Schoemann, François Goldwasser, et al.
Expert Opinion on Investigational Drugs|January 21, 2015
Investigational therapies up to Phase II which target PDGF receptors: potential anti-cancer therapeuticsJennifer Arrondeau, Olivier Huillard, Camille Tlemsani, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 30, 2024
Pulmonary metastasectomy for sarcoma: Insights from a referral-center cohortThomas Charrier, Edouard-Frédéric Robin, Vincent De Pauw, et al.
Pageof 13